Evidence map›Paper›PMID 42357619›Full record

ArticleViruses2026

Post-Pandemic Genomic Diversity and Lineage Turnover of Influenza Viruses in Mexico During 2022-2023.

Blanca Taboada, Selene Zárate, José Esteban Muñoz-Medina, Joel Armando Vazquez-Perez, Alejandro Sanchez-Flores, Angel Gustavo Salas-Lais, Alejandro Uscanga Junco, Alida Zárate, Larissa Fernandes-Matano, Luis Antonio Uribe-Noguez and 3 more

Abstract read
In one paragraph

Article in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Blanca TaboadaDepartamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca 62210, Morelos, Mexico.
Selene ZáratePosgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, Ciudad de México 03100, Mexico.ORCID 0000-0003-1034-204X
José Esteban Muñoz-MedinaCoordinación de Calidad de Insumos y Laboratorios Especializados, Instituto Mexicano del Seguro Social, Ciudad de México 07760, Mexico.
Joel Armando Vazquez-PerezInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Ciudad de México 14080, Mexico.
Alejandro Sanchez-FloresUnidad Universitaria de Secuenciación Masiva y Bioinformática, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca 62210, Morelos, Mexico.ORCID 0000-0003-0476-3139
Angel Gustavo Salas-LaisCoordinación de Calidad de Insumos y Laboratorios Especializados, Instituto Mexicano del Seguro Social, Ciudad de México 07760, Mexico.ORCID 0000-0003-3757-6209
Alejandro Uscanga JuncoInstituto de Investigación en Ciencias Básicas Aplicadas (IICBA), Universidad Autónoma del Estado de Morelos, Cuernavaca 62210, Morelos, Mexico.
Alida ZárateDepartamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca 62210, Morelos, Mexico.ORCID 0009-0006-5407-6598
Larissa Fernandes-MatanoCoordinación de Calidad de Insumos y Laboratorios Especializados, Instituto Mexicano del Seguro Social, Ciudad de México 07760, Mexico.ORCID 0000-0001-7599-1046
Luis Antonio Uribe-NoguezLaboratorio Central de Epidemiología, Instituto Mexicano del Seguro Social, Ciudad de México 02990, Mexico.ORCID 0000-0003-2452-782X
Enrique Mendoza-RamírezInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Ciudad de México 14080, Mexico.ORCID 0009-0009-4900-5965
Fidencio Mejía-NepomucenoInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Ciudad de México 14080, Mexico.
Carlos F AriasDepartamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca 62210, Morelos, Mexico.ORCID 0000-0003-3130-4501

Funding

National Autonomous University of Mexico PAPIIT-DGAPA-IN230523Secretaría de Educación, Ciencia, Tecnología e Innovación SECTEI/138/2024
6 · The paper itself

Abstract

Seasonal influenza circulation was profoundly disrupted during the COVID-19 pandemic, resulting in an unprecedented global decline in viral activity and genetic diversity. As non-pharmaceutical interventions gradually relaxed, influenza viruses re-emerged in multiple regions in 2022; however, genomic data from Latin America remain limited, particularly for the first post-pandemic season. In this study, we analyzed the epidemiological, genomic, and evolutionary patterns of influenza A and B viruses circulating in Mexico between June 2018 and June 2023, with a specific focus on the first post-pandemic season (June 2022-June 2023). More than 90% of the influenza virus genomes available from Mexico for this post-pandemic period were generated in this study, while data from earlier seasons were used for contextualization. Following a near-complete absence of influenza circulation during 2020-2021, viral activity re-emerged in late 2021 and intensified during 2022-2023. Post-pandemic circulation in Mexico was dominated by influenza A(H3N2), with a lower contribution from A(H1N1)pdm09 and a delayed re-emergence of B/Victoria; B/Yamagata was not detected. Genomic analyses revealed rapid lineage turnover after the pandemic, characterized by the predominance of post-pandemic clades and reduced genetic diversity compared with pre-pandemic seasons. Phylogenetic analyses indicated multiple introductions and strong regional connectivity across North and South America.

Indexed as

Genetic VariationGenome, ViralInfluenza A virusInfluenza B virusInfluenza, HumanEvolution, MolecularGenomicsHumansInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeMexicoPandemicsPhylogenySeasonsgenomic surveillanceinfluenzaMexicovirus evolution

Identifiers

PMID42357619
PMCPMC13308283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.